Literature DB >> 15815631

Ipr1 gene mediates innate immunity to tuberculosis.

Hui Pan1, Bo-Shiun Yan, Mauricio Rojas, Yuriy V Shebzukhov, Hongwei Zhou, Lester Kobzik, Darren E Higgins, Mark J Daly, Barry R Bloom, Igor Kramnik.   

Abstract

An estimated eight million people are infected each year with the pathogen Mycobacterium tuberculosis, and more than two million die annually. Yet only about 10% of those infected develop tuberculosis. Genetic variation within host populations is known to be significant in humans and animals, but the nature of genetic control of host resistance to tuberculosis remains poorly understood. Previously we mapped a new genetic locus on mouse chromosome 1, designated sst1 (for supersusceptibility to tuberculosis 1). Here we show that this locus mediates innate immunity in sst1 congenic mouse strains and identify a candidate gene, Intracellular pathogen resistance 1 (Ipr1), within the sst1 locus. The Ipr1 gene is upregulated in the sst1 resistant macrophages after activation and infection, but it is not expressed in the sst1 susceptible macrophages. Expression of the Ipr1 transgene in the sst1 susceptible macrophages limits the multiplication not only of M. tuberculosis but also of Listeria monocytogenes and switches a cell death pathway of the infected macrophages from necrosis to apoptosis. Our data indicate that the Ipr1 gene product might have a previously undocumented function in integrating signals generated by intracellular pathogens with mechanisms controlling innate immunity, cell death and pathogenesis.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15815631      PMCID: PMC1388092          DOI: 10.1038/nature03419

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  30 in total

1.  Tuberculosis--the global view.

Authors:  Barry R Bloom
Journal:  N Engl J Med       Date:  2002-05-09       Impact factor: 91.245

Review 2.  The TB epidemic from 1992 to 2002.

Authors:  Mario C Raviglione
Journal:  Tuberculosis (Edinb)       Date:  2003       Impact factor: 3.131

3.  Crystal structure and nuclear magnetic resonance analyses of the SAND domain from glucocorticoid modulatory element binding protein-1 reveals deoxyribonucleic acid and zinc binding regions.

Authors:  Paola Lo Surdo; Matthew J Bottomley; Michael Sattler; Klaus Scheffzek
Journal:  Mol Endocrinol       Date:  2003-04-17

4.  The primary mechanism of attenuation of bacillus Calmette-Guerin is a loss of secreted lytic function required for invasion of lung interstitial tissue.

Authors:  Tsungda Hsu; Suzanne M Hingley-Wilson; Bing Chen; Mei Chen; Annie Z Dai; Paul M Morin; Carolyn B Marks; Jeevan Padiyar; Celia Goulding; Mari Gingery; David Eisenberg; Robert G Russell; Steven C Derrick; Frank M Collins; Sheldon L Morris; C Harold King; William R Jacobs
Journal:  Proc Natl Acad Sci U S A       Date:  2003-10-13       Impact factor: 11.205

5.  Modulation of retinoid signaling by a cytoplasmic viral protein via sequestration of Sp110b, a potent transcriptional corepressor of retinoic acid receptor, from the nucleus.

Authors:  Koichi Watashi; Makoto Hijikata; Ayako Tagawa; Takahiro Doi; Hiroyuki Marusawa; Kunitada Shimotohno
Journal:  Mol Cell Biol       Date:  2003-11       Impact factor: 4.272

Review 6.  Body language: the function of PML nuclear bodies in apoptosis regulation.

Authors:  T G Hofmann; H Will
Journal:  Cell Death Differ       Date:  2003-12       Impact factor: 15.828

Review 7.  The growing burden of tuberculosis: global trends and interactions with the HIV epidemic.

Authors:  Elizabeth L Corbett; Catherine J Watt; Neff Walker; Dermot Maher; Brian G Williams; Mario C Raviglione; Christopher Dye
Journal:  Arch Intern Med       Date:  2003-05-12

8.  Toll-like receptor 4-defective C3H/HeJ mice are not more susceptible than other C3H substrains to infection with Mycobacterium tuberculosis.

Authors:  Arati B Kamath; Jennifer Alt; Hajer Debbabi; Samuel M Behar
Journal:  Infect Immun       Date:  2003-07       Impact factor: 3.441

9.  Pulmonary necrosis resulting from DNA vaccination against tuberculosis.

Authors:  Jennifer L Taylor; Oliver C Turner; Randall J Basaraba; John T Belisle; Kris Huygen; Ian M Orme
Journal:  Infect Immun       Date:  2003-04       Impact factor: 3.441

Review 10.  The secret lives of the pathogenic mycobacteria.

Authors:  Christine L Cosma; David R Sherman; Lalita Ramakrishnan
Journal:  Annu Rev Microbiol       Date:  2003       Impact factor: 15.500

View more
  203 in total

1.  Dose-ranging comparison of rifampin and rifapentine in two pathologically distinct murine models of tuberculosis.

Authors:  Ian M Rosenthal; Rokeya Tasneen; Charles A Peloquin; Ming Zhang; Deepak Almeida; Khisimuzi E Mdluli; Petros C Karakousis; Jacques H Grosset; Eric L Nuermberger
Journal:  Antimicrob Agents Chemother       Date:  2012-06-04       Impact factor: 5.191

2.  Differential Mycobacterium bovis BCG vaccine-derived efficacy in C3Heb/FeJ and C3H/HeOuJ mice exposed to a clinical strain of Mycobacterium tuberculosis.

Authors:  Marcela Henao-Tamayo; Andrés Obregón-Henao; Elizabeth Creissen; Crystal Shanley; Ian Orme; Diane J Ordway
Journal:  Clin Vaccine Immunol       Date:  2014-11-12

Review 3.  Forward genetic dissection of innate response to infection in inbred mouse strains: selected success stories.

Authors:  S Gruenheid; P Gros
Journal:  Clin Exp Immunol       Date:  2010-12       Impact factor: 4.330

4.  Alpha-galactosylceramide as a therapeutic agent for pulmonary Mycobacterium tuberculosis infection.

Authors:  Isabel Sada-Ovalle; Markus Sköld; Tian Tian; Gurdyal S Besra; Samuel M Behar
Journal:  Am J Respir Crit Care Med       Date:  2010-05-27       Impact factor: 21.405

5.  Disseminated and rapidly fatal tuberculosis in mice bearing a defective allele at IFN regulatory factor 8.

Authors:  Jean-François Marquis; Ronald LaCourse; Lynn Ryan; Robert J North; Philippe Gros
Journal:  J Immunol       Date:  2009-03-01       Impact factor: 5.422

6.  Characterization of a novel necrotic granuloma model of latent tuberculosis infection and reactivation in mice.

Authors:  Noton K Dutta; Peter B Illei; Sanjay K Jain; Petros C Karakousis
Journal:  Am J Pathol       Date:  2014-05-09       Impact factor: 4.307

Review 7.  Genetics-squared: combining host and pathogen genetics in the analysis of innate immunity and bacterial virulence.

Authors:  Jenny Persson; Russell E Vance
Journal:  Immunogenetics       Date:  2007-09-14       Impact factor: 2.846

8.  Evaluation of moxifloxacin-containing regimens in pathologically distinct murine tuberculosis models.

Authors:  Si-Yang Li; Scott M Irwin; Paul J Converse; Khisi E Mdluli; Anne J Lenaerts; Eric L Nuermberger
Journal:  Antimicrob Agents Chemother       Date:  2015-04-27       Impact factor: 5.191

9.  Dynamic imaging in patients with tuberculosis reveals heterogeneous drug exposures in pulmonary lesions.

Authors:  Alvaro A Ordonez; Hechuan Wang; Gesham Magombedze; Camilo A Ruiz-Bedoya; Shashikant Srivastava; Allen Chen; Elizabeth W Tucker; Michael E Urbanowski; Lisa Pieterse; E Fabian Cardozo; Martin A Lodge; Maunank R Shah; Daniel P Holt; William B Mathews; Robert F Dannals; Jogarao V S Gobburu; Charles A Peloquin; Steven P Rowe; Tawanda Gumbo; Vijay D Ivaturi; Sanjay K Jain
Journal:  Nat Med       Date:  2020-02-17       Impact factor: 53.440

Review 10.  Mechanisms and consequences of macrophage apoptosis in atherosclerosis.

Authors:  Tracie Seimon; Ira Tabas
Journal:  J Lipid Res       Date:  2008-10-25       Impact factor: 5.922

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.